“The 2 antibodies that make up MBP134 were isolated from a survivor of the 2013-2016 Ebola outbreak in West Africa..MBP134 then proved capable of protecting ferrets and rhesus macaques from three ebolaviruses, including Bundibugyo” https://www.fiercebiotech.com/biotech/us-taps-small-san-diego-biotech-experimental-ebola-treatment-epidemic-worsens?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotechResearch&oly_enc_id=8120G8600990B0C